Coronary Artery DiseaseLEARNERSNCT06589323
Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in CABG (LEARNERS)
An observational study of Coronary Artery Disease, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.
Trial summary
Transit-time flowmetry (TTFM) allows grafts quality assessment during coronary artery bypass surgery by measuring the flow volume through them. Recently the intraoperative epicardial high-frequency ultrasound (HFUS) was introduced, with the possibility of capturing bidimensional images of the anastomoses. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Coronary Artery Disease
- What is being tested?
- Coronary artery bypass graft
- Type of treatment
- Surgery or procedure
- How many people
- 80 participants
- Where
- 1 siteItaly
- Study dates
- 15 Sep 2024to 1 Apr 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.
Who may be able to join
- Age >= 18 years old;
- Written informed consent;
- Indication to CABG surgery (both "on-pump" and "off-pump");
- Stable angina, unstable angina or acute coronary syndrome without ST elevation (NSTEMI).
Who cannot join
- Age >= 18 years old;
- Written informed consent;
- Indication to CABG surgery (both "on-pump" and "off-pump");
- Stable angina, unstable angina or acute coronary syndrome without ST elevation (NSTEMI).
Trial locations and contacts
1 site in 1 country.
Italy1 site
Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Roma, RM, 00168
About this study
Official title: Cardiac Surgery Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in Coronary Artery Bypass Surgery: the LEARNERS Study
Transit-time flowmetry (TTFM) allows grafts quality assessment during coronary artery bypass surgery by measuring the flow volume through them. Recently the intraoperative epicardial high-frequency ultrasound (HFUS) was introduced, with the possibility of capturing bidimensional images of the anastomoses. When combined, these two techniques provide high diagnostic yield reaching a positive predictive value of 100 percent.
Despite current guidelines recommend the employment of TTFM and HFUS, they remain largely underused probably because of limited information and the lack of standardization. Furthermore, surgeons must overcome a learning curve to handle both techniques properly, but few data are available according the current literature.
The main purpose of this study is to evaluate the complexity of HFUS and TTFM learning curve. This is a prospective, observational, monocentric cohort study. Adult patients undergoing coronary artery bypass surgery will be enrolled.
Read the detailed description
This is a prospective, observational, monocentric cohort study in which adult patients undergoing coronary artery bypass surgery will be enrolled.
Primary objective of this study is to evaluate the complexity of cardiac surgery residents' learning curve for grafts quality assessment with transit-time flowmetry (TTFM) and intraoperative epicardial high-frequency ultrasound (HFUS).
Secondary objectives are to evaluate the complexity of cardiac surgery residents' learning curve for grafts quality assessment with TTFM and HFUS as isolated techniques.
The study will last four months (three months for patients enrollment and data collection and one month for statistical analysis and scientific paper writing).
The trial will start after obtaining favourable opinion from the local Ethics Committee and could be considered completed when all the eight cardiac surgery residents involved have reached primary endpoint.
All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.
Patient data (anamnestic data, surgery description, intraoperative echographic and flowmetric measurements) will be recorded in a dedicated database. All data recorded in the database are commonly acquired for all patients undergoing this type of surgery and no further examinations will be performed for patients included in the trial.
The study will involve cardiac surgery residents with different levels of training and an expert cardiac surgeon who acts as supervisor and benchmark. Each resident will sign a dedicated informed consent form in the presence of a doctor foreign to the study protocol (Cardiac Surgery ward cardiologist). The residents will be "blinded" about the trial objective and the adopted score system. They will undergo a specific training including a quick lesson and a practical workshop to familiarize with the equipment.
During surgery, every graft will be evaluated through transit time flowmetry (TTFM) and intraoperative ultrasound control (HFUS).
In details, the ultrasound control is carried out through a dedicated sterile ultrasound probe connected to a machine (MiraQ - MEDISTIM) as soon as each anastomosis is completed. The result of the evaluation is recorded together with surgery data. This evaluation is intended to confirm the correct realization of the anastomosis and provides a proof of its patency.
Once each graft is completed, the resident will be given 60 seconds to acquire two HFUS recordings (short and long axis). After that, the supervisor will perform his personal recording which will stand as benchmark. The following items will be evaluated:
- Long axis recording acquired within 60 seconds [YES-> 1] [NO -> 0] B) Long axis recording judged as suitable by the supervisor [YES -> 1] [NO -> 0] C) Short axis recording acquired within 60 seconds [YES -> 1] [NO -> 0] D) Short axis recording judged as suitable by the supervisor [YES -> 1] [NO -> 0]
- Correct interpretation of the anastomosis as adequate or inadequate [YES -> no penalty] [NO -> total score becomes 0 and the resident isn't allowed to perform TTFM]
Each resident will be given a HFUS-related score from a minimum of 0 to a maximum of 4.
Whenever one of the recordings will be judged as non-suitable by the supervisor and consequently useless for a correct interpretation of the anastomosis (score 0 for items A and/or C), item E won't be evaluated and the HFUS will be given a total score of 0.
Next step will be the TFM evaluation, which is carried out through a specific sterile device connected to the same machine (MiraQ - MEDISTIM) once the patient has been weaned from the cardiopulmonary bypass and before protamine administration. This recording is performed under EKG and pressure-controlled conditions. Although there is no general agreement on the optimal mean arterial pressure at which the measurement has to be recorded, the investigators will adopt the standard used in the REQUEST study protocol (16), that is an average pressure of 80 mmHg.
The resident will acquire the TTFM recording after each graft is completed. To make the comparison as accurate as possible, the resident will perform TTFM evaluation on one graft at a time and successively the supervisor will do the same for each graft (making sure that delta between the pressure during the two recordings is lower than 10 percent and that no drug has been administered). The following items will be evaluated:
- Time necessary to acquire the measures [< 30 sec -> 1] [> 30 sec, < 60 -> 0.5] [> 60 sec -> 0] G) Need for multiple measurements before the final one: [>2 -> 0] [1 -> 0.5] [ 0 -> 1] H) Need to change probe dimensions: [NO -> 0] [YES-> 1]
- ACI [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] L) Mean Flow [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] M) Pulsatility Index [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] N) Backward Flow [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] O) Diastolic Filling [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0]
- Correct interpretation of the graft quality as working [YES -> no penalty] [NO -> total score becomes 0]
Each resident will be given a TTFM-related score from a minimum of 0 to a maximum of 8.
The final score for each graft will be the sum of the two scores (HFUS and TTFM), from a minimum of 0 to a maximum of 12.
The same procedure will be repeated for each graft performed during the surgery.
Each resident will continue until reaching a ratio between total score and number of evaluated anastomoses of 11.
Our cardiac surgery unit performs between 5 and 10 coronary artery bypass grafts surgeries per week on average. Considering the inclusion and exclusion criteria and assuming that some patient may not give their informed consent, the investigators expect to enroll 4 patients per week. Considering that the involved residents (8 in total) will take part to the procedures in turn and that around 10 surgeries are needed to become autonomous, the investigators estimate to enroll 80 patients during a period of 3 months.
Data will be collected in a specific database (Microsoft Excel worksheet). The Kolgomorov-Smirnoff test was used to check for variables distribution. Continuous variables with a normal distribution are summarized by mean and standard deviation. Continuous variables with a non-normal distribution are expressed with median and interquartile range.
Categorical variables are reported as absolute frequency distribution and percentage. Continuous data are analyzed using the unpaired t-test or the Mann - Whitney test according to their distribution. Categorical data are compared with the Fisher's exact test. Statistical findings were considered significant if p value was less than 0.05. Statistical analysis will be performed with the statistic software SPSS (IBM).
- Conditions
- Coronary Artery Disease
- Being tested
- Coronary artery bypass graft
- Medical subject headings
- Coronary Artery Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Coronary artery bypass graftProcedure or surgery
All patients included will undergo coronary artery bypass graft surgery. During surgery, every graft will be evaluated through transit time flowmetry (TTFM) and intraoperative ultrasound control (HFUS).
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | adult patients undergoing coronary artery bypass surgery Receives: Procedure: Coronary artery bypass graft |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of anastomoses needed to reach a ratio (total score/n. of anastomoses) >= 11
Number of anastomoses needed to reach a ratio between total score and the number of studied anastomoses of 11 or more
Measured: This evaluation will require from 1 to 3 months.
Secondary outcomes (2)
Number of anastomoses needed to reach a ratio (HFUS score/n. of anastomoses) = 4
Number of anastomoses needed to reach a ratio between the HFUS score and the number of studied anastomoses of 4
Measured: This evaluation will require from 1 to 3 months.
Number of anastomoses needed to reach a ratio (TTFM score/n. of anastomoses) >=7
Number of anastomoses needed to reach a ratio between the TTFM score and the number of studied anastomoses of 7 or more
Measured: This evaluation will require from 1 to 3 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start15 Sep 2024
- Primary completion1 Apr 2025
- Study completion1 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (16)Papers the sponsor has linked to this study.
- Other trials for Coronary Artery DiseaseStudies of the same condition, open and under way.
- More trials run by Fondazione Policlinico Universitario Agostino Gemelli IRCCSThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Federico Cammertoni, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Investigators
- Federico Cammertoni, Dr., Principal investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06589323
- Sponsor's protocol ID
- 6735
- Acronym
- LEARNERS
- Status last verified
- Sep 2024
- First submitted
- 27 Aug 2024
- Last updated
- 2 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394. No abstract available.
PubMed 30165437Kieser TM, Rose S, Kowalewski R, Belenkie I. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. Eur J Cardiothorac Surg. 2010 Aug;38(2):155-62. doi: 10.1016/j.ejcts.2010.01.026. Epub 2010 Feb 21.
PubMed 20176493Kieser TM, Taggart DP. The use of intraoperative graft assessment in guiding graft revision. Ann Cardiothorac Surg. 2018 Sep;7(5):652-662. doi: 10.21037/acs.2018.07.06.
PubMed 30505750Amin S, Pinho-Gomes AC, Taggart DP. Relationship of Intraoperative Transit Time Flowmetry Findings to Angiographic Graft Patency at Follow-Up. Ann Thorac Surg. 2016 May;101(5):1996-2006. doi: 10.1016/j.athoracsur.2015.10.101. Epub 2016 Feb 12.
PubMed 26876343Di Giammarco G, Pano M, Cirmeni S, Pelini P, Vitolla G, Di Mauro M. Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgery. J Thorac Cardiovasc Surg. 2006 Sep;132(3):468-74. doi: 10.1016/j.jtcvs.2006.02.014.
PubMed 16935097Xenogiannis I, Zenati M, Bhatt DL, Rao SV, Rodes-Cabau J, Goldman S, Shunk KA, Mavromatis K, Banerjee S, Alaswad K, Nikolakopoulos I, Vemmou E, Karacsonyi J, Alexopoulos D, Burke MN, Bapat VN, Brilakis ES. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies. Circulation. 2021 Aug 31;144(9):728-745. doi: 10.1161/CIRCULATIONAHA.120.052163. Epub 2021 Aug 30.
PubMed 34460327Di Giammarco G, Canosa C, Foschi M, Rabozzi R, Marinelli D, Masuyama S, Ibrahim BM, Ranalletta RA, Penco M, Di Mauro M. Intraoperative graft verification in coronary surgery: increased diagnostic accuracy adding high-resolution epicardial ultrasonography to transit-time flow measurement. Eur J Cardiothorac Surg. 2014 Mar;45(3):e41-5. doi: 10.1093/ejcts/ezt580. Epub 2013 Dec 12.
PubMed 24335472Gaudino M, Sandner S, Di Giammarco G, Di Franco A, Arai H, Asai T, Bakaeen F, Doenst T, Fremes SE, Glineur D, Kieser TM, Lawton JS, Lorusso R, Patel N, Puskas JD, Tatoulis J, Taggart DP, Vallely M, Ruel M. The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements. Circulation. 2021 Oct 5;144(14):1160-1171. doi: 10.1161/CIRCULATIONAHA.121.054311. Epub 2021 Oct 4.
PubMed 34606302Kieser TM. Graft quality verification in coronary artery bypass graft surgery: how, when and why? Curr Opin Cardiol. 2017 Nov;32(6):722-736. doi: 10.1097/HCO.0000000000000452.
PubMed 28806185Andreasen JJ, Nohr D, Jorgensen AS, Haahr PE. Peroperative epicardial ultrasonography of distal coronary artery bypass graft anastomoses using a stabilizing device. A feasibility study. J Cardiothorac Surg. 2020 Jan 8;15(1):3. doi: 10.1186/s13019-020-1057-x.
PubMed 31915030Andreasen JJ, Nohr D, Jorgensen AS. A case report on epicardial ultrasonography of coronary anastomoses using a stabilizing device without the use of ultrasound gel. J Cardiothorac Surg. 2019 Mar 13;14(1):59. doi: 10.1186/s13019-019-0882-2.
PubMed 30866994Wolf RK, Falk V. Intraoperative assessment of coronary artery bypass grafts. J Thorac Cardiovasc Surg. 2003 Sep;126(3):634-7. doi: 10.1016/s0022-5223(03)00747-5. No abstract available.
PubMed 14502132Budde RP, Meijer R, Dessing TC, Borst C, Grundeman PF. Detection of construction errors in ex vivo coronary artery anastomoses by 13-MHz epicardial ultrasonography. J Thorac Cardiovasc Surg. 2005 May;129(5):1078-83. doi: 10.1016/j.jtcvs.2004.09.002.
PubMed 15867783Jorgensen AS, Schmidt SE, Staalsen NH, Ostergaard LR. An Improved Algorithm for Coronary Bypass Anastomosis Segmentation in Epicardial Ultrasound Sequences. Ultrasound Med Biol. 2016 Dec;42(12):3010-3021. doi: 10.1016/j.ultrasmedbio.2016.07.014. Epub 2016 Sep 2.
PubMed 27592558Taggart DP, Thuijs DJFM, Di Giammarco G, Puskas JD, Wendt D, Trachiotis GD, Kieser TM, Kappetein AP, Head SJ. Intraoperative transit-time flow measurement and high-frequency ultrasound assessment in coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2020 Apr;159(4):1283-1292.e2. doi: 10.1016/j.jtcvs.2019.05.087. Epub 2019 Aug 22.
PubMed 31685277
Study at a glance
From the registry record, last updated by the sponsor on 2 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cardiac Surgery Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in Coronary Artery Bypass Surgery: the LEARNERS Study
- ClinicalTrials.gov ID
- NCT06589323
- Acronym / sponsor ID
- LEARNERS / 6735
- Conditions
- Coronary Artery Disease
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSUniversity, hospital or other
- Study start
- 15 Sep 2024 (actual)
- Primary completion
- 1 Apr 2025 (actual)
- Study completion
- 1 Apr 2025 (actual)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Transit-time flowmetry (TTFM) allows grafts quality assessment during coronary artery bypass surgery by measuring the flow volume through them. Recently the intraoperative epicardial high-frequency ultrasound (HFUS) was introduced, with the possibility of capturing bidimensional images of the anastomoses. When combined, these two techniques provide high diagnostic yield reaching a positive predictive value of 100 percent.
Despite current guidelines recommend the employment of TTFM and HFUS, they remain largely underused probably because of limited information and the lack of standardization. Furthermore, surgeons must overcome a learning curve to handle both techniques properly, but few data are available according the current literature.
The main purpose of this study is to evaluate the complexity of HFUS and TTFM learning curve. This is a prospective, observational, monocentric cohort study. Adult patients undergoing coronary artery bypass surgery will be enrolled.
Detailed description
This is a prospective, observational, monocentric cohort study in which adult patients undergoing coronary artery bypass surgery will be enrolled.
Primary objective of this study is to evaluate the complexity of cardiac surgery residents' learning curve for grafts quality assessment with transit-time flowmetry (TTFM) and intraoperative epicardial high-frequency ultrasound (HFUS).
Secondary objectives are to evaluate the complexity of cardiac surgery residents' learning curve for grafts quality assessment with TTFM and HFUS as isolated techniques.
The study will last four months (three months for patients enrollment and data collection and one month for statistical analysis and scientific paper writing).
The trial will start after obtaining favourable opinion from the local Ethics Committee and could be considered completed when all the eight cardiac surgery residents involved have reached primary endpoint.
All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.
Patient data (anamnestic data, surgery description, intraoperative echographic and flowmetric measurements) will be recorded in a dedicated database. All data recorded in the database are commonly acquired for all patients undergoing this type of surgery and no further examinations will be performed for patients included in the trial.
The study will involve cardiac surgery residents with different levels of training and an expert cardiac surgeon who acts as supervisor and benchmark. Each resident will sign a dedicated informed consent form in the presence of a doctor foreign to the study protocol (Cardiac Surgery ward cardiologist). The residents will be "blinded" about the trial objective and the adopted score system. They will undergo a specific training including a quick lesson and a practical workshop to familiarize with the equipment.
During surgery, every graft will be evaluated through transit time flowmetry (TTFM) and intraoperative ultrasound control (HFUS).
In details, the ultrasound control is carried out through a dedicated sterile ultrasound probe connected to a machine (MiraQ - MEDISTIM) as soon as each anastomosis is completed. The result of the evaluation is recorded together with surgery data. This evaluation is intended to confirm the correct realization of the anastomosis and provides a proof of its patency.
Once each graft is completed, the resident will be given 60 seconds to acquire two HFUS recordings (short and long axis). After that, the supervisor will perform his personal recording which will stand as benchmark. The following items will be evaluated:
- Long axis recording acquired within 60 seconds [YES-> 1] [NO -> 0] B) Long axis recording judged as suitable by the supervisor [YES -> 1] [NO -> 0] C) Short axis recording acquired within 60 seconds [YES -> 1] [NO -> 0] D) Short axis recording judged as suitable by the supervisor [YES -> 1] [NO -> 0]
- Correct interpretation of the anastomosis as adequate or inadequate [YES -> no penalty] [NO -> total score becomes 0 and the resident isn't allowed to perform TTFM]
Each resident will be given a HFUS-related score from a minimum of 0 to a maximum of 4.
Whenever one of the recordings will be judged as non-suitable by the supervisor and consequently useless for a correct interpretation of the anastomosis (score 0 for items A and/or C), item E won't be evaluated and the HFUS will be given a total score of 0.
Next step will be the TFM evaluation, which is carried out through a specific sterile device connected to the same machine (MiraQ - MEDISTIM) once the patient has been weaned from the cardiopulmonary bypass and before protamine administration. This recording is performed under EKG and pressure-controlled conditions. Although there is no general agreement on the optimal mean arterial pressure at which the measurement has to be recorded, the investigators will adopt the standard used in the REQUEST study protocol (16), that is an average pressure of 80 mmHg.
The resident will acquire the TTFM recording after each graft is completed. To make the comparison as accurate as possible, the resident will perform TTFM evaluation on one graft at a time and successively the supervisor will do the same for each graft (making sure that delta between the pressure during the two recordings is lower than 10 percent and that no drug has been administered). The following items will be evaluated:
- Time necessary to acquire the measures [< 30 sec -> 1] [> 30 sec, < 60 -> 0.5] [> 60 sec -> 0] G) Need for multiple measurements before the final one: [>2 -> 0] [1 -> 0.5] [ 0 -> 1] H) Need to change probe dimensions: [NO -> 0] [YES-> 1]
- ACI [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] L) Mean Flow [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] M) Pulsatility Index [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] N) Backward Flow [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] O) Diastolic Filling [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0]
- Correct interpretation of the graft quality as working [YES -> no penalty] [NO -> total score becomes 0]
Each resident will be given a TTFM-related score from a minimum of 0 to a maximum of 8.
The final score for each graft will be the sum of the two scores (HFUS and TTFM), from a minimum of 0 to a maximum of 12.
The same procedure will be repeated for each graft performed during the surgery.
Each resident will continue until reaching a ratio between total score and number of evaluated anastomoses of 11.
Our cardiac surgery unit performs between 5 and 10 coronary artery bypass grafts surgeries per week on average. Considering the inclusion and exclusion criteria and assuming that some patient may not give their informed consent, the investigators expect to enroll 4 patients per week. Considering that the involved residents (8 in total) will take part to the procedures in turn and that around 10 surgeries are needed to become autonomous, the investigators estimate to enroll 80 patients during a period of 3 months.
Data will be collected in a specific database (Microsoft Excel worksheet). The Kolgomorov-Smirnoff test was used to check for variables distribution. Continuous variables with a normal distribution are summarized by mean and standard deviation. Continuous variables with a non-normal distribution are expressed with median and interquartile range.
Categorical variables are reported as absolute frequency distribution and percentage. Continuous data are analyzed using the unpaired t-test or the Mann - Whitney test according to their distribution. Categorical data are compared with the Fisher's exact test. Statistical findings were considered significant if p value was less than 0.05. Statistical analysis will be performed with the statistic software SPSS (IBM).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Procedure: Coronary artery bypass graftadult patients undergoing coronary artery bypass surgery |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.
Key inclusion criteria (4 listed)
- Age >= 18 years old;
- Written informed consent;
- Indication to CABG surgery (both "on-pump" and "off-pump");
- Stable angina, unstable angina or acute coronary syndrome without ST elevation (NSTEMI).
Key exclusion criteria (4 listed)
- Age >= 18 years old;
- Written informed consent;
- Indication to CABG surgery (both "on-pump" and "off-pump");
- Stable angina, unstable angina or acute coronary syndrome without ST elevation (NSTEMI).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Coronary artery bypass graftAll patients included will undergo coronary artery bypass graft surgery. During surgery, every graft will be evaluated through transit time flowmetry (TTFM) and intraoperative ultrasound control (HFUS). | Procedure or surgery | Group 1 |
Primary outcome
Number of anastomoses needed to reach a ratio (total score/n. of anastomoses) >= 11
Time frame: This evaluation will require from 1 to 3 months.
Number of anastomoses needed to reach a ratio between total score and the number of studied anastomoses of 11 or more
2 secondary outcomes
Number of anastomoses needed to reach a ratio (HFUS score/n. of anastomoses) = 4
Time frame: This evaluation will require from 1 to 3 months.
Number of anastomoses needed to reach a ratio (TTFM score/n. of anastomoses) >=7
Time frame: This evaluation will require from 1 to 3 months.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jan 2026.
- Results publication: PubMed 30165437Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394. No abstract available.
- Results publication: PubMed 20176493Kieser TM, Rose S, Kowalewski R, Belenkie I. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. Eur J Cardiothorac Surg. 2010 Aug;38(2):155-62. doi: 10.1016/j.ejcts.2010.01.026. Epub 2010 Feb 21.
- Results publication: PubMed 30505750Kieser TM, Taggart DP. The use of intraoperative graft assessment in guiding graft revision. Ann Cardiothorac Surg. 2018 Sep;7(5):652-662. doi: 10.21037/acs.2018.07.06.
- Results publication: PubMed 26876343Amin S, Pinho-Gomes AC, Taggart DP. Relationship of Intraoperative Transit Time Flowmetry Findings to Angiographic Graft Patency at Follow-Up. Ann Thorac Surg. 2016 May;101(5):1996-2006. doi: 10.1016/j.athoracsur.2015.10.101. Epub 2016 Feb 12.
- Results publication: PubMed 16935097Di Giammarco G, Pano M, Cirmeni S, Pelini P, Vitolla G, Di Mauro M. Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgery. J Thorac Cardiovasc Surg. 2006 Sep;132(3):468-74. doi: 10.1016/j.jtcvs.2006.02.014.
- Results publication: PubMed 34460327Xenogiannis I, Zenati M, Bhatt DL, Rao SV, Rodes-Cabau J, Goldman S, Shunk KA, Mavromatis K, Banerjee S, Alaswad K, Nikolakopoulos I, Vemmou E, Karacsonyi J, Alexopoulos D, Burke MN, Bapat VN, Brilakis ES. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies. Circulation. 2021 Aug 31;144(9):728-745. doi: 10.1161/CIRCULATIONAHA.120.052163. Epub 2021 Aug 30.
- Results publication: PubMed 24335472Di Giammarco G, Canosa C, Foschi M, Rabozzi R, Marinelli D, Masuyama S, Ibrahim BM, Ranalletta RA, Penco M, Di Mauro M. Intraoperative graft verification in coronary surgery: increased diagnostic accuracy adding high-resolution epicardial ultrasonography to transit-time flow measurement. Eur J Cardiothorac Surg. 2014 Mar;45(3):e41-5. doi: 10.1093/ejcts/ezt580. Epub 2013 Dec 12.
- Results publication: PubMed 34606302Gaudino M, Sandner S, Di Giammarco G, Di Franco A, Arai H, Asai T, Bakaeen F, Doenst T, Fremes SE, Glineur D, Kieser TM, Lawton JS, Lorusso R, Patel N, Puskas JD, Tatoulis J, Taggart DP, Vallely M, Ruel M. The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements. Circulation. 2021 Oct 5;144(14):1160-1171. doi: 10.1161/CIRCULATIONAHA.121.054311. Epub 2021 Oct 4.
- Results publication: PubMed 28806185Kieser TM. Graft quality verification in coronary artery bypass graft surgery: how, when and why? Curr Opin Cardiol. 2017 Nov;32(6):722-736. doi: 10.1097/HCO.0000000000000452.
- Results publication: PubMed 31915030Andreasen JJ, Nohr D, Jorgensen AS, Haahr PE. Peroperative epicardial ultrasonography of distal coronary artery bypass graft anastomoses using a stabilizing device. A feasibility study. J Cardiothorac Surg. 2020 Jan 8;15(1):3. doi: 10.1186/s13019-020-1057-x.
- Results publication: PubMed 30866994Andreasen JJ, Nohr D, Jorgensen AS. A case report on epicardial ultrasonography of coronary anastomoses using a stabilizing device without the use of ultrasound gel. J Cardiothorac Surg. 2019 Mar 13;14(1):59. doi: 10.1186/s13019-019-0882-2.
- Results publication: PubMed 14502132Wolf RK, Falk V. Intraoperative assessment of coronary artery bypass grafts. J Thorac Cardiovasc Surg. 2003 Sep;126(3):634-7. doi: 10.1016/s0022-5223(03)00747-5. No abstract available.
- Individual participant dataSharing planned: No
Related trials for Coronary Artery Disease
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
RecruitingObservational study
Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
Coronary Artery Disease, Left Ventricular Systolic Dysfunction
Active, not recruiting
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
Ischaemic Heart Disease, Ischemic Heart Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Federico Cammertoni, Dr. principal investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Coronary Artery Disease, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of anastomoses needed to reach a ratio (total score/n. of anastomoses) >= 11 (time frame: This evaluation will require from 1 to 3 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06589323, which also lists 16 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.